Skip to main content
Oncotarget logoLink to Oncotarget
. 2018 Oct 16;9(81):35285. doi: 10.18632/oncotarget.26255

Correction: EGFR kinase domain mutation positive lung cancers are sensitive to intrapleural perfusion with hyperthermic chemotherapy (IPHC) complete treatment

Hongjuan Zhang 1,2, Cheng Zhan 2, Ji Ke 3, Zhiqiang Xue 4, Aiqun Zhang 4, Kaifeng Xu 5, Zhirong Shen 2,6, Lei Yu 3, Liang Chen 2,7
PMCID: PMC6219665  PMID: 30443297

This article has been corrected: The correct Acknowledgment information is given below:

ACKNOWLEDGMENT

This work was funded by National Natural Science Foundation of China grant 81472606, Chinese Ministry of Science and Technology grant (973 grant) 2011CB812401, and the Beijing Municipal Government.

Original article: Oncotarget. 2016; 7:3367-3378. https://doi.org/10.18632/oncotarget.6491


Articles from Oncotarget are provided here courtesy of Impact Journals, LLC

RESOURCES